Virtus Investment Advisers, Inc. Acadia Pharmaceuticals Inc Transaction History
Virtus Investment Advisers, Inc.
- $289 Million
- Q1 2025
A detailed history of Virtus Investment Advisers, Inc. transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Virtus Investment Advisers, Inc. holds 20,804 shares of ACAD stock, worth $463,929. This represents 0.12% of its overall portfolio holdings.
Number of Shares
20,804
Previous 39,370
47.16%
Holding current value
$463,929
Previous $722,000
52.22%
% of portfolio
0.12%
Previous 0.61%
Shares
2 transactions
Others Institutions Holding ACAD
# of Institutions
351Shares Held
165MCall Options Held
1.77MPut Options Held
307K-
Baker Bros. Advisors LP New York, NY42.9MShares$956 Million8.49% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.2MShares$339 Million0.0% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$269 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY8.54MShares$190 Million2.32% of portfolio
-
State Street Corp Boston, MA6.99MShares$156 Million0.0% of portfolio
About ACADIA PHARMACEUTICALS INC
- Ticker ACAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 161,843,008
- Market Cap $3.61B
- Description
- ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...